Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 48 ($0.62) and last traded at GBX 48 ($0.62), with a volume of 11 shares changing hands. The stock had previously closed at GBX 49.50 ($0.64).
Arecor Therapeutics Trading Down 3.0 %
The business has a 50 day moving average of GBX 54.75 and a 200 day moving average of GBX 66.62. The firm has a market cap of £18.12 million, a price-to-earnings ratio of -1.70 and a beta of -0.18. The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Articles
- Five stocks we like better than Arecor Therapeutics
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What is a buyback in stocks? A comprehensive guide for investors
- Alphabet’s Officially In A Bear Market—Time To Buy?
- The Role Economic Reports Play in a Successful Investment Strategy
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
